Abstract:As a specific microvascular complication of diabetes, diabetic retinopathy (DR) causes severe visual impairment in patients with diabetes. The expression of microRNA‑126 (miRNA/miR‑126) has previously been found to be significantly decreased in the serum of patients with DR. In the present study, the functions of miR‑126 and its mechanisms of action in experimental diabetic retinopathy were examined in rats with streptozotocin (STZ)‑induced diabetes and in high glucose (HG)‑induced human retinal capillary endothelial cells (HRCECs). In vivo, diabetic rat models were established and the rats were intravitreally injected with lentivirus expressing rno‑miR‑126 (lenti‑miR‑126) or negative control (lenti‑NC). RT‑qPCR was used to determine the miR‑126 level in the serum and retina. Paraffin sections and retinal vasculature were used to determine the extent of retinopathy. The protein content of vascular endothelial growth factor (VEGF) and pigment epithelium‑derived factor (PEDF) in the retina was used as an auxiliary measurement of retinopathy. Western blot analysis and immunofluorescence staining were used to measure the expression of polo‑like kinase 4 (PLK4) in rat retinal tissue. In vitro, the cells were transfected with miR‑126 inhibitor or mimic and treated with the PLK4 inhibitor, CFI‑400945 fumarate. RT‑qPCR and western blot analysis were used to detect the miR‑126 level and PLK4 expression. Cell proliferation and migration were measured by EdU and Transwell assays. The diabetic rats were found to exhibit downregulated serum and retinal miR‑126 levels compared with the non‑diabetic rats. The intravitreal delivery of miR‑126 alleviated retinopathy and reduced the diabetes‑induced upregulation of PLK4 in retinal tissues. Luciferase reporter assays confirmed that PLK4 mRNA was the target of miR‑126. In HG‑induced HRCECs, transfection with miR‑126 mimic increased the miR‑126 level, whereas it downregulated that of its downstream target, PLK4, which was opposite to the effects exerted by the miR‑126 inhibitor. Furthermore, miR‑126 mimic and CFI‑400945 fumarate reduced the HG‑induced upregulation of PLK4 expression, as well as cell proliferation and migration. On the whole, the findings of the present study demonstrate that miR‑126 reduces experimental diabetic retinopathy and suppresses endothelial cell proliferation and migration by targeting PLK4. Thus, miR‑126 and CFI‑400945 fumarate may be therapeutic targets for DR.

MiR-18b Suppresses High-Glucose-induced Proliferation in HRECs by Targeting IGF-1/IGF1R Signaling Pathways

MiRNA-144-3p Inhibits High Glucose Induced Cell Proliferation Through Suppressing FGF16.

Upregulation of miR‐192‐5p inhibits the ELAVL1/PI3Kδ axis and attenuates microvascular endothelial cell proliferation, migration and angiogenesis in diabetic retinopathy

MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy

Upregulation of miR-181 a-5 p represses VEGF pathway in high glucose treated human retinal endothelial cells

MiR-199a-3p inhibits the proliferation, migration, and invasion of endothelial cells and retinal pericytes of diabetic retinopathy rats through regulating FGF7 via EGFR/PI3K/AKT pathway

MicroRNA-15b Targets VEGF and Inhibits Angiogenesis in Proliferative Diabetic Retinopathy

MiR-124-3p Suppresses the Dysfunction of High Glucose-Stimulated Endothelial Cells by Targeting G3BP2

miR-142-5p regulates the progression of diabetic retinopathy by targeting IGF1

MicroRNA-148a-3p alleviates high glucose-induced diabetic retinopathy by targeting TGFB2 and FGF2

Upregulation of miR-424 inhibit retinal endothelial cells proliferation under high glucose condition via cyclin D1

Circ_0001897 regulates high glucose-induced angiogenesis and inflammation in retinal microvascular endothelial cells through miR-29c-3p/transforming growth factor beta 2 axis

LncRNA MIR497HG Inhibits Proliferation and Migration of Retinal Endothelial Cells under High-Level Glucose Treatment Via Mirna-128-3p/sirt1 Axis.

Ginsenoside Rg1 Inhibits High Glucose-Induced Proliferation, Migration, and Angiogenesis in Retinal Endothelial Cells by Regulating the lncRNA SNHG7/miR-2116-5p/SIRT3 Axis

MicroRNA-135b-5p promotes endothelial cell proliferation and angiogenesis in diabetic retinopathy mice by inhibiting Von Hipp-el-Lindau and elevating hypoxia inducible factor expression

MiR-99a-5p Inhibits the Proliferation and Migration of Human Retinal Microvascular Endothelial Cells by Targeting NOX4

Differentially Expressed Micrornas in the Development of Early Diabetic Retinopathy

Overexpression of histone deacetylase SIRT1 exerts an antiangiogenic role in diabetic retinopathy via miR-20a elevation and YAP/HIF1α/VEGFA depletion

LncRNA H19 Inhibits High Glucose‐induced Inflammatory Responses of Human Retinal Epithelial Cells by Targeting Mir‐19b to Increase SIRT1 Expression

MiR‐203a‐3p Inhibits Retinal Angiogenesis and Alleviates Proliferative Diabetic Retinopathy in Oxygen‐induced Retinopathy (OIR) Rat Model Via Targeting VEGFA and HIF‐1α

MicroRNA‐126 suppresses the proliferation and migration of endothelial cells in experimental diabetic retinopathy by targeting polo‐like kinase 4